Anti-tau antibody treatment improves motor and cognitive performance in HD mice expressing mHTTex1 (Alpaugh et al., 2022), suggesting active involvement of tau pathology in HD neuropathogenesis. This evidence concerns the gene MAPT and Huntington disease.